Blog
RSS FeedPosted by Michael Wonder on 22 Feb 2018
Federal right-to-try legislation — threatening the FDA’s public health mission
22 February 2018 - A bill passed by the Senate would sharply curtail the FDA’s oversight of access to investigational drugs. ...
Posted by Michael Wonder on 08 Feb 2018
Rejuvenating regenerative medicine regulation
7 February 2018 - The FDA recently made long-awaited progress toward protecting patients from interventions involving human cell- and tissue-based products ...
Posted by Michael Wonder on 05 Feb 2018
Standard deviation and standard error: interpretation, usage and reporting
5 February 2018 - Standard deviations and standard errors are reported routinely in statistical analyses, but the distinction between them is ...
Posted by Michael Wonder on 01 Feb 2018
Advance notice of consultation about changes to the Pharmaceutical Schedule Rules
1 February 2018 - PHARMAC is working to make the Pharmaceutical Schedule Rules easier to find, use and apply. ...
Posted by Michael Wonder on 31 Jan 2018
Health policy reform not helped by Bill Shorten
31 January 2018 - It is noteworthy that shares in Medibank Private hit a record high the day after Opposition ...
Posted by Michael Wonder on 31 Jan 2018
A better way to disrupt health care
31 January 2018 - The new alliance of Amazon, Berkshire Hathaway and JPMorgan Chase shows promise. ...
Posted by Michael Wonder on 29 Jan 2018
Rare disease medicine changes offer clarity
29 January 2018 - Proposed changes to the provision of medicines for rare diseases should bring greater certainty for people ...
Posted by Michael Wonder on 29 Jan 2018
Medicines Australia welcomes LSDP review outcomes
28 January 2018 - Medicines Australia welcomes the Government’s announcement of an outcome from the post-market review of the Life ...
Posted by Michael Wonder on 28 Jan 2018
Review of the Life Saving Drugs Program - final report and Government response
28 January 2018 - After nearly 4 years and 3 health ministers, the final report and Government's response to the ...
Posted by Michael Wonder on 23 Jan 2018
The one year anniversary of the Oncology Center of Excellence
19 January 2018 - One year ago, 19 January 2017, FDA officially launched the Oncology Center of Excellence to leverage the ...
Posted by Michael Wonder on 23 Jan 2018
Human medicines: highlights of 2017
23 January 2018 - 92 medicines recommended for approval, including 35 with a new active substance. ...
Posted by Michael Wonder on 18 Jan 2018
Early benefit assessments: the 220th dossier evaluation completed at the turn of the year
18 January 2018 - Oncology remains by far the most common indication. ...
Posted by Michael Wonder on 16 Jan 2018
Statement from FDA Commissioner in response to GAO report regarding FDA’s ongoing commitment to employing a least burdensome approach to device review
16 January 2018 - To encourage innovation and provide patients with access to the latest safe and effective medical technologies, we ...
Posted by Michael Wonder on 16 Jan 2018
How Ottawa's using a fake drug crisis to force through damaging pharmaceutical policy
16 January 2018 - There is no affordability crisis to justify expanding drug price regulation, or a new national government-run pharmacare ...
Posted by Michael Wonder on 16 Jan 2018
In a nutshell 2017: new issue with facts and graphics from the IQWiG
15 January 2018 - Third issue with focus on quality assurance/numerous graphs illustrate work results. ...